Our gallery of selected references and projects illustrates the variety of requests that Hello Healthcare receives, as well as our ability to provide solutions that meet our clients’ needs.
Hedera Dx was founded in 2021 with a clear mission: to provide oncologists with more precise and less invasive tumor insights through cutting-edge liquid biopsy technology. The company streamlines the complex landscape of molecular cancer testing with a single, integrated solution that detects SNVs, Indels, CNVs, gene fusions, and MSI status — all in a DNA-only workflow.
Since 2025, Hello Healthcare is supporting Hedera Dx in developing the German market. We are driving strategic partnerships with molecular pathology laboratories to help integrate this innovative technology into the German healthcare system.
From left to right: Sanga Mitra Boppudi, Damien Lapray and Frieda Gerdes at the 108th Annual Congress of the German Pathology Society in Leipzig, 2025
The company asked us to update the corporate design and reposition the company and its services. Moreover, the tasks included setting up an automated lead generation system and developing of key marketing tools like:
The company asked us to develop and execute a strategic marketing plan for its main product MH Guide, incl. sales, marketing, medical affairs and market access activities:
Exact Sciences acquired the US company Genomic Health at the end of 2019, following its success in Europe. A large part of this success was the reimbursement of its breast cancer test Oncotype DX®. Hello Healthcare had the pleasure of working for Genomic Health Germany for many years to achieve the goal of an EBM code* for Oncotype DX.
From 2012 to 2019, we orchestrated a combination of marketing, market access and medical affairs activities to achieve this goal:
*An EBM code in the ambulatory care setting enables reimbursement for a medical service.
